Pharmaceutical Packaging, as a very active area of China's packaging branch, its constantly updated with the progress of the packaging industry has witnessed rapid development. China's accession to WTO, more international pharmaceutical companies began to enter China, and in this regard intensified competition in China's pharmaceutical industry, it also improves the quality and the industry technical standards to drive the development of pharmaceutical packaging has become a kind of inevitable. As the pharmaceutical industry and the people's daily lives, creating a pharmaceutical packaging specificity.
Therefore, in our country, the medical packaging attributable to the State Food and Drug Supervision and Management areas. However, the technical level point of view, medical packaging and packaging printing relations are very large, concerned about the medical packaging will become a kind of reasoning where one is based on the background, we were interviewed in China Packaging Technology Association, packaging and printing, secretary general of Mr. Chen Qixiang and Shanghai Pharmaceutical Packaging Test Chi-wai, director of President, to the common interpretation of domestic pharmaceutical packaging market.
Pharmaceutical Packaging Status Perspective
At present, China's pharmaceutical companies are mainly distributed in Jiangsu, Zhejiang and Guangdong provinces, in terms of quantity and from the scale that Guangdong and Zhejiang in the vicinity of pharmaceutical companies are dominant. From the perspective of the development the past two years, pharmaceutical companies increasingly apparent large-scale production and grades, is gradually improving, the modern pharmaceutical companies a developing trend in the larger laboratories are equipped with their own packaging business.
At present, high-speed, low efficiency. High consumption of extensive growth is the development of China's pharmaceutical packaging typical characteristics of domestic quality of the packaging of pharmaceutical products in most grades low, and there are still a big gap between the developed countries. This is evident from the following two data can be corroborated, Currently, there are less than 65:6 pharmaceutical packaging products to the international developed country on the 20th century, the age levels of 0, the quality of packaging materials and packaging to the pharmaceutical industry's contribution rate is low. In developed countries, medical packaging pharmaceuticals accounted for the value of 30:6, while the proportion of China's less than 10%. At present, for the domestic large-scale pharmaceutical packaging businesses in the device compared with foreign countries, the gap is not, but in the software environment is very unsatisfactory.
It is understood that the reason for this difference mainly in three aspects: first, a lower overall level of China's pharmaceutical industry, pharmaceutical manufacturers the technology is relatively backward. From the size of pharmaceutical companies, China's pharmaceutical enterprises in number, repeat the process on a serious drugs, pharmaceuticals low level of corporate governance. Second, China's pharmaceutical packaging industry-related regulations and technical standards behind.
At present, China has gradually introduced the pharmaceutical industry specification standard system, but there are still some distance from the international standard. Industry-standard system for packaging of pharmaceutical products due to the absence of both good and bad situation. Finally, drug distribution system plagued by problems. The long-term sales of pharmaceutical products to hospitals mainly in pharmacies sell drugs only a small part of the total, which limited the drug directly involved in market competition, restricted the development of pharmaceutical packaging.
In addition, the current drug bidding system has seriously hurt the enthusiasm of pharmaceutical manufacturers, enterprises can not make great effort to reform the packaging, pharmaceutical packaging to keep old faces a long time. In addition, pharmaceutical packaging machinery equipment and materials, the technological level of backwardness is not strong quality awareness of employees is also constrained the development of China's pharmaceutical product packaging factors.
Pharmaceutical Packaging Development Road
As China's health care system reform, medical packaging disorder. Situation in backward fundamental change will occur. At present, China is constantly introducing and updating of medical packaging machinery and materials, pharmaceutical packaging industry will appear in a new situation. Drug types of diversity, but also to bring about diversification in the form of pharmaceutical packaging in recent years, China's solid-type drugs, such as hormone tablets, capsules, capsule, injection, medication packaging updates externally bonded very quickly, while disposable plastic syringe the use of packaging and application to the Chinese injection to bring a big change, big infusion packages are also moving in the direction of improved composite flexible packaging bags and plastic bottles direction.
Institute of Economic Research by the National Development and Reform Commission and the Beijing Xinhua Online Information Technology Co., Ltd. jointly launched the "second quarter of 2003 the economy of China Pharmaceutical Industry Analysis Report" shows that by "SARS" the impact of the second quarter of this year, production of various trades and professions medicine growth in the first place. From January to June of this year, the pharmaceutical industry of industrial output 1433. S2 billion (current prices) over the same period last year 21.55%; according to constant price statistics, the pharmaceutical industrial output value of 183.09 billion yuan, an increase of 24.82%. In short, within the next few years look at the prospects of China's development of Chinese medicine, can be predicted that the future of pharmaceutical packaging in China's rapid development.
According to the U.S. Flexible Packaging Association reported that, by 2003, the world of basic packaging needs of pharmaceutical products will have 4.2% growth in total output value will reach 11.2 billion U.S. dollars in the next five years, the medical packaging will become the second largest flexible packaging industry, economic growth. To seize this opportunity, experts believe that China's Pharmaceutical Packaging should do the following: First, promote the use of drugs to speed up Liquid Plastic containers; second, accelerate the development of Chinese medicine plastic hollow container packaging, should be more used to HDPE, PP, PET, PEN and other materials, and using injection blow molding process such as production of hollow plastic containers. In the hollow container mouth using electromagnetic induction aluminum foil sealing gasket in order to enhance the safety of drug protection; the same time, promote the use of Chinese medicine to speed up the plastic composite film bag.
It should be said, pharmaceutical packaging in the next few years will see rapid development, the prospects for good, a large space. After single-dose packaging of drugs, more and more overseas pharmaceutical companies have begun to flood the Chinese market, how to seize this opportunity of China's pharmaceutical packaging business worth consideration.
